Caxton Corp Rezolute, Inc. Transaction History
Caxton Corp
- $15.8 Million
- Q4 2024
A detailed history of Caxton Corp transactions in Rezolute, Inc. stock. As of the latest transaction made, Caxton Corp holds 1,318,967 shares of RZLT stock, worth $5.84 Million. This represents 39.88% of its overall portfolio holdings.
Number of Shares
1,318,967
Previous 1,318,967
-0.0%
Holding current value
$5.84 Million
Previous $6.4 Million
1.64%
% of portfolio
39.88%
Previous 27.47%
Shares
4 transactions
Others Institutions Holding RZLT
# of Institutions
76Shares Held
44.6MCall Options Held
201KPut Options Held
2.8K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$50 Million0.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.86MShares$12.7 Million0.69% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$12.4 Million2.6% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$11.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$10.3 Million0.0% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $172M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...